Quick answer: North Carolina has not legalized medical or adult-use cannabis, but two bills are shaping the debate. Senate Bill 1072 (SB 1072) would create a regulated medical cannabis program with licensing for cultivation, manufacturing, testing, distribution, and retail. House Bill 328 (HB 328) would regulate hemp-derived cannabinoid products with licensing, age limits, testing, and labeling standards. Together they signal where North Carolina cannabis policy may be heading.

Key takeaways

• SB 1072 targets a state-regulated *medical cannabis* program and a full licensing framework.
• HB 328 targets *hemp-derived cannabinoid* regulation, not marijuana legalization.
• Neither bill legalizes adult-use cannabis in North Carolina.
• Operators and investors should monitor both, as either could create new licensing and compliance obligations.

North Carolina remains one of the few states without a comprehensive medical or adult-use cannabis program, but lawmakers continue to introduce legislation that could reshape the state’s approach to cannabis policy. Two bills have drawn particular attention: Senate Bill 1072 (SB 1072) and House Bill 328 (HB 328). Each addresses cannabis differently, and together they reflect the ongoing conversation around legalization, regulation, and patient access in North Carolina.

SB 1072: Expanding Medical Cannabis Access

SB 1072 builds on previous efforts to establish a regulated medical cannabis program in North Carolina. Like earlier proposals, it seeks to give qualifying patients legal access to cannabis for certain medical conditions under the supervision of licensed healthcare providers. Key components include:

• Establishing a state-regulated medical cannabis program
• Defining qualifying medical conditions for patient eligibility
• Creating a licensing framework for cultivation, manufacturing, testing, distribution, and retail
• Implementing product testing, labeling, and packaging requirements
• Establishing oversight and compliance standards for licensed businesses

Supporters argue the legislation would provide patients an alternative treatment option while maintaining strict regulatory controls. Opponents continue to raise concerns about implementation, public health, and broader cannabis policy.

HB 328: Hemp and Cannabinoid Regulation

HB 328 focuses on regulating hemp-derived cannabinoid products that became widely available following the 2018 Farm Bill. The legislation aims to create clearer standards for products containing hemp-derived cannabinoids, including:

• Licensing and registration requirements for businesses
• Age restrictions for consumers
• Product testing and labeling standards
• Packaging requirements designed to protect consumers
• Enforcement mechanisms for non-compliant products

As the hemp market evolves, lawmakers have sought consistent regulations that promote consumer safety while giving businesses clarity.

A Changing Cannabis Landscape

Although neither medical nor adult-use cannabis is fully legal in North Carolina, proposals like SB 1072 and HB 328 demonstrate continued interest in addressing both patient access and cannabinoid regulation. Businesses considering future opportunities in the state should monitor legislative developments closely, since changes to state law could create new licensing opportunities and compliance obligations. Hemp businesses, likewise, should stay attentive to evolving requirements that may affect manufacturing, distribution, retail operations, and product standards.

Looking Ahead

North Carolina’s cannabis policy continues to evolve through legislative debate and stakeholder engagement. Whether through expanded medical cannabis, tighter oversight of hemp-derived products, or future reforms, the state’s legal framework remains a developing area worth watching. For patients, businesses, and investors, staying informed about proposals such as SB 1072 and HB 328 is essential for understanding where North Carolina’s cannabis industry may be headed, and for preparing for future regulatory change.

Frequently Asked Questions

Is cannabis legal in North Carolina?

No. As of this writing, North Carolina has not legalized medical or adult-use cannabis. However, bills such as SB 1072 (medical cannabis) and HB 328 (hemp-derived cannabinoids) are under legislative consideration.

What would SB 1072 do?

SB 1072 would establish a state-regulated medical cannabis program in North Carolina, including qualifying conditions for patients and a licensing framework for cultivation, manufacturing, testing, distribution, and retail, along with testing, labeling, and compliance standards.

What is the difference between SB 1072 and HB 328?

SB 1072 addresses a regulated *medical cannabis* program for patients. HB 328 addresses regulation of *hemp-derived cannabinoid* products, including licensing, age restrictions, testing, and labeling. Neither legalizes adult-use marijuana.

How should businesses prepare for cannabis changes in North Carolina?

By monitoring legislation closely and preparing for potential licensing and compliance requirements. Because state law could change, businesses and investors benefit from understanding the proposals now and building readiness before any program launches.

How CBA Can Help

The Cannabis Business Advisors help operators and investors track state-by-state legislation and prepare for new licensing opportunities before they open. Contact our team to build a North Carolina readiness strategy.